Efficacy of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

2008 ◽  
Vol 58 (2) ◽  
pp. AB133
Keyword(s):  
Clinical Trial ◽  
Latin America ◽  
Plaque Psoriasis ◽  
Open Label ◽  
Severe Plaque Psoriasis ◽  
Phase Iiib ◽  
Open Label Phase

scholarly journals Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results

2009 ◽  
Vol 2 (4) ◽  
pp. 71-78 ◽  
Author(s):  
Fernando M. Stengel ◽  
Valeria Petri ◽  
Gladys A.M. Campbell ◽  
Gladys Leon Dorantes ◽  
Magdalina López ◽  
...  
Keyword(s):  
Latin American ◽  
Plaque Psoriasis ◽  
American Study ◽  
Latin American Study ◽  
Open Label ◽  
Severe Plaque Psoriasis ◽  
Study Results ◽  
Phase Iiib ◽  
Open Label Phase

REGOMA: A Randomized, Multicenter, Controlled Open-Label Phase II Clinical Trial of Regorafenib Compared to Lomustine in Relapsed Glioblastoma Patients

2018 ◽  
Author(s):  
Giuseppe Lombardi ◽  
Gian Luca De Salvo ◽  
Alba Ariela Brandes ◽  
Marica Eoli ◽  
Roberta Rudà ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
Phase Ii Clinical Trial ◽  
Open Label ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document